Macrogol is an osmotic laxative that draws water into the bowel to soften stools and is recommended by NICE as first-line treatment for chronic constipation in adults Constipation affects 1-10% of Ozempic users and over 10% of Wegovy users, caused by semaglutide's effect on gastrointestinal motility Bulk-forming laxatives like ispaghula husk may suit mild constipation but require adequate fluid intake to prevent obstruction Stimulant laxatives such as senna or bisacodyl provide short-term relief for severe constipation and should be used under medical supervision No specific laxative interactions with Ozempic are documented, but patients should inform healthcare providers of all medications taken Persistent or severe constipation, abdominal pain, vomiting, or inability to pass stool requires urgent medical assessment Not sure where to start
Preclinical data suggest it may be orders of magnitude more potent than BDNF in this specific function, though human translation of that potency ratio is not established
Pinching a fold of skin and fat lifts it away from the underlying muscle, creating a safe subcutaneous target
It is calculated by first figuring out your Basal Metabolic Rate, then multiplying that value by an activity multiplier
Increasing too quickly can generate more side effects
This suggests that GLP-1 receptor activation alone may not substantially increase deficiency risk
